The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 150 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
Vision:
The Centre for Bioengineering & Biotechnology (CBB) enables interdisciplinary research across the university to address global challenges in human health and help translate those research results rapidly into practice, policy and impactful health outcomes. Achieving this vision will help the University of Waterloo to cement an international reputation at the interface of technology and human health.
Mission:
To achieve this vision, CBB's mission is to:
- Enable knowledge translation and support of the interdisciplinary research community through seminars, networking opportunities, and support of student groups
- Be a conduit to Waterloo's ecosystem of unique health related R&D and clinical resources
- Cultivate relationships with key stakeholders in technology, human, animal and environmental health and practice including industry, hospitals, community, and international bodies
- Provide Project Coordination/Management for large/inter-institutional projects
Join us:
To become a member of CBB, you can start by filling out a quick survey. We will then be in touch to discuss further.
News
CBB members Roderick Slavcev, Emmanuel Ho and Marc Aucoin team up to develop DNA-based COVID-19 vaccine
Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.
The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.
PPE for infectious disease preparedness featured in research paper from 2016 relevant for response to COVID-19
The current COVID-19 pandemic has been putting a strain on healthcare workers around the world. We often forget all the challenges that frontline healthcare professionals have to face, including the use of personal protective equipment. This paper from 2016 describes the evaluation during the ebola crisis, which has excellent recommendations for healthcare workers and managers around the world when dealing with COVID-19.
CBB member Alexander Wong's research uses open-source software to improve COVID-19 screening with AI
Researchers at the University of Waterloo have partnered with an artificial intelligence (AI) startup on a project that aims to use AI to improve COVID-19 screening.
The Waterloo research team publicly released AI software that can better detect infections from chest x-rays and is looking to enlist expertise from around the world to aid in the project.